The Authority of the HPRA is appointed by the Minister for Health in accordance with the powers conferred by subsection 2 of section 7 of the Irish Medicines Board Act, 1995.
Ms. Ann Horan (MAFC, FCCA, FIB) is Chairperson of the HPRA. Prior to this role, she was CEO of the DCU Ryan Academy for Entrepreneurs. Ann’s career includes senior executive roles in regulation, banking, small business and education. She served on boards including Dublin City University, the Institute of Bankers, South Dublin Chamber of Commerce and chaired associations including the UK based Factors & Discounters Association and the International Women’s Forum. Through her successful career, she developed expertise in the areas of leadership, strategic planning, financial control, risk management, technology and corporate governance. She has proven ability to operate in both the public and private sectors and has direct experience in the areas of regulation and investment management. Ann is an accountant with a Masters in Finance from DCU.
Professor David Kerins has served as a member of the Advisory Committee for Human Medicines of the Irish Medicines Board/Health Products Regulatory Authority since 2006.
He received a BSc in Physiology in 1981, and an MB, BAO, BCh from University College Cork in 1984. He completed sequential fellowships in Clinical Pharmacology and in Clinical Cardiology at Vanderbilt University, Nashville TN. Following appointments as an Associate Professor of Medicine and Chief of the Cardiology Section at Nashville VA. He was appointed as Associate Professor of Therapeutics at University College Cork and Consultant Physician at Mercy University Hospital in 2006, and served as Dean of the Medical School, UCC from 2007-2010, and as Clinical Director of Mercy University Hospital from 2012-2017.
He has research interests in anti-platelet and anti-thrombotic therapy, vascular biology with a particular focus on the renin-angiotensin and fibrinolytic pathways, and non-invasive cardiac imaging. Professor Kerins is a fellow of the American Heart Association, the American College of Cardiology, the European Society of Cardiology, the American Society of Echocardiography and the British Pharmacological Society. He is a Consultant Cardiologist at Mercy University Hospital.
Mr. David Holohan (BCOMM, MBA, APA, C Dir, M.Inst.D, CMgr FCMI, Chartered FCSI) is Head of Equity Strategy at Mediolanum’s Irish operations having previously been Chief Investment Officer at Merrion Capital (2010-2018). He was was appointed to the Board of the HPRA by the Minister for Health in January 2016. Before joining Merrion in 2010, he was a Partner at a Dublin based investment firm and previously worked for a multi-billion dollar European hedge fund situated in London. David holds a Bachelor of Commerce degree from University College Dublin and an MBA with merit from Imperial College London. He is a Chartered Director (UK) and Member of the Institute of Directors (Ireland). David is also a Chartered Fellow of the Chartered Institute for Securities & Investment (UK) and a Chartered Fellow of the Chartered Management Institute (UK). David is Chairman of the Governing Body of IADT and is a Member of the National Oversight and Audit Commission (NOAC). He is also Non-Executive Chairman of the charity, One in Four. David is regularly cited for his business and investment opinions by both Irish and international media.
Mr Brian Jones was appointed to the Board of the HPRA by the Minister for Health in January 2016. Brian is Group CEO of the Partnership of East London Cooperatives, a not-for-profit Social Enterprise providing clinical services to 1.1 million patients in North East London. With experience of leading a multi-skilled clinical team, operating within a rapidly changing healthcare system, he has an understanding of working collegially with partners from across multi-agency stakeholders to deliver outstanding care to the populations they serve.
His experience has provided him with a deep understanding of clinical governance and risk, enabling his organisations to create environments in which excellence in clinical care can flourish. This has been demonstrated by him taking a service from CQC 'Special measures' to 'Good' with 'Outstanding features' within nine months of his appointment to the Group CEO post.
Prior to his most recent role, Brian spent seven years within public health, responsible for crisis and emergency preparedness within the most high profile and sensitive geographies in London.
Dr. Elizabeth Keane - MB, MPH, FFPHMI. A consultant in Public Health Medicine, Dr. Keane is Adjunct Professor of Epidemiology and Public Health in the School of Public Health in UCC. Dr. Keane worked in hospital medicine for 5 years prior to undertaking a Masters in Public Health in UCD and completed Higher Specialist Training in Public Health Medicine in 1989. She was appointed the first Director of Public Health for Cork and Kerry in 1995. Dr. Keane was Dean of the Faculty of Public Health Medicine of the RCPI from 2014 to 2017. In addition, Dr Keane is an Examiner for the Membership Examinations. She is a former Chair of both the National Cancer Registry Board and the Board of the National Disease Surveillance Centre (now HPSC). She has also served on the boards of the Irish Blood Transfusion Service and the Interim Health Information and Quality Authority. Dr. Keane’s main areas of interest include health status epidemiology, health protection, the public health aspects of blood borne viruses and international health regulations.
Professor Caitriona O’Driscoll (BSc Pharm., PhD, MPSI) is Professor and Chair of Pharmaceutics in the School of Pharmacy, University College Cork (UCC). Professor O’Driscoll was appointed as the first Head of the School of Pharmacy at UCC in 2003 and she served as Head from 2003-09 and 2010-13. Professor O’Driscoll completed her PhD in Pharmaceutics at the University of Dublin, Trinity College, Ireland. She held the post of senior lecturer in Pharmaceutics at Trinity College until 2003. Professor O’Driscoll is a Council member of the Pharmaceutical Society of Ireland. Research interests include the design of drug delivery systems which exploit the physiological environment and utilise cell specific targeting to overcome the barriers to absorption. Candidate drugs include macromolecules, peptides/proteins, genes and poorly water-soluble compounds. Delivery systems of interest are: lipid-based vehicles and non-viral gene delivery systems employing modified cyclodextrins, nanoparticles and receptor-ligand mediated targeting.
Dr. Diarmuid Quinlan - MB, BCh, BAO, BSc (Hons), MICGP, MRCGP, Masters in Medical Law & Ethics (merit), DCH, DFFP, Dip Practical Dermatology (distinction). Dr. Quinlan works as a GP in Glanmire, Co. Cork. He is a graduate of UCC, completed specialist training in General Practice in Kent, England and then worked in Australia prior to returning to Cork. He is a director of Diabetes in General Practice, a diabetes charity. He is the National Clinical Lead for Diabetes in Primary Care. He is on the Cork committee of the Southdoc out-of-hours service. He is a clinical risk advisor in primary care, with the Medical Protection Society. He won the ICGP Quality in Practice award in 2013 and 2018. He is an undergraduate tutor in UCC and an online dermatology tutor for Cardiff University, Wales. He is a medical columnist for a number of publications.
Professor Richard Reilly is Professor of Neural Engineering at Trinity College, The University of Dublin. This post is a joint position between the School of Medicine and School of Engineering. He a Principal Investigator of the Trinity Centre for Biomedical Engineering (TCBE) and also a Principal Investigator at the Trinity College Institute of Neuroscience (TCIN). His research interests are in clinical neural engineering based on signal processing of electrophysiological, neuroimaging and bioacoustic data for the development of quantitative methods to understand neural function and the underlying pathophysiology of sensory and cognitive processing.
He is a member of the Royal Irish Academy and Fellow of the European Alliance for Medical and Biological Engineering & Science and Fellow of the Royal Academy of Medicine in Ireland. He was awarded the Haughton Medal from the Royal Academy of Medicine of Ireland in 2013. In 2004 he was awarded a US Fulbright Award for research collaboration into multisensory integration with the Nathan Kline Institute for Psychiatric Research, New York. Professor Reilly received his BE degree in Electronic Engineering, a MEngSc and a PhD in Biomedical Engineering from University College Dublin.